While previous studies on regenerative therapy using FGF-2 have reported only short-term outcomes, this study, based on data from a medium-term observation period of 3 years, showed a trend of improvement in RBD even after 6 months postoperatively, which is consistent with the findings of our previous study in which EMD was used [ 19 ].
← all excerpts
Prognostic factors affecting periodontal regenerative therapy using recombinant human fibroblast growth factor-2: A 3-year cohort study.
1
—
—